REFERENCES
- Albers GW. Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Clin Neuropharmacol. 1990;13:177–197.
- Rothman SM, Olney JW. Glutamate and the pathophysi-ology of hypoxic-ischemic brain damage. Ann Neurol. 1986;19:105–111.
- Choi DW, Maullucci-Gedde MA, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7:357–368.
- Choi DW, Koh J, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci. 1988; 8(1):185–196.
- Frandsen A, Drejer J, Schousboe A. Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA re-ceptors. J Neurochem. 1989;53(1):297–299.
- Silverstein FS, Buchanan K, Johnston MV. Perinatal hypoxia-ischemia disrupts striatal high affinity [3H] glutamate uptake into synaptosomes. J Neurochem. 1986; 47:1614–1619.
- Goldberg MP, Kurth MC, Giffard RG, Choi DW. Cal-cium accumulation and intracellular calcium during in vitro "ischemia." Soc Neurosci Abstr. 1989;15:803.
- Kogure K, Kato H. Neurochemistry of stroke. In: Barnett HJM, Stein BM, Mohr JP, Yatsu FM, eds. Stroke: Pat ho-physiology, Diagnosis, and Management, 2nd ed. London: Churchill Livingstone;1992:69–101.
- Jaffrey SR, Snyder SH. Nitric oxide: a neural messenger. Annu Rev Cell Dev Biol. 1995;11:417–440.
- Faden AI. Opioids and nonopioid mechanisms may con-tribute to dynorphin's pathophysiological actions in spi-nal cord injury. Ann Neurol. 1990;27(1):64–67.
- Peters S, Koh J, Choi DW. Zinc selectivity blocks the action of N-methyl-D-aspartate on cortical neurons. Sci-ence. 1987;236: 589–593.
- Westbrook GL, Mayer ML. Micromolar concentrations of zinc antagonize NMDA and GABA responses of hippocampal neurons. Nature. 1987;328:640–643.
- Lodge D, Jines M, Fletcher E. Non-competitive antago-nists of N- methyl-D-aspartate. In: Watkins JC, Collingridge GL, eds. The NMDA Receptor. London: Oxford University Press;1989.
- Kulagowski JJ, Leeson PD. Glycine-site NMDA receptor antagonists. Exp Opin Ther Patents. 1995;5(10):1061–1075.
- Dixon R, Howes J, Gentile J, et al. Nalmefene: intrave-nous safety and kinetics of a new opioid antagonist Clin Pharmacol Ther. 1986;39(1):49–53.
- Tietjen GE, Dombi T, Pusinelli WA, Becske T, Kugler AR, Mann ME. A double-blind, safety, and tolerance study of single intravenous doses of fosphenytoin in patients with acute ischemic stroke. Neurology. 1996;46(2):A424–A425.
- Weiss GB. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicholine. Life Sci. 1995;56(9):637–660.
- Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, Omae T, Fujishima M, Sakuma A. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke. 1988;19(2):211–216.
- Anonymous. Interneuron's citicholine beneficial in stroke. Scrip. February 27, 1996; 2106:21.
- Diener HC, Hacke W, Hennerici M, Radberg J, Hanston L, De Keyser J for the Lubeluzole International Study Group. Lubeluzole in acute ischemic stroke: a double-blind, placebo-controlled phase II trial. Stroke. 1996;27(1):76–78.
- Hacke W, Hennerici H, Hanston L, Diener HC. Lubeluzole: a new neuroprotectant agent in the treatment of acute ischemic stroke: results of a cardiovascular safety study in stroke patients. Neurology. 1996;46(2):A429.
- Meldrum B. Protection against ischemic neuronal dam-age by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev. 1990;2:27–57.
- Cross AJ, Jones JA, Baldwin HA, Green AR. Neuro-protective activity of clomethiazole following transient forebrain ischemia in the gerbil. Br J Pharmacol. 1991;104:406–411.
- Vincens M, Enjalbert A, Lloyd K, et al. Evidence that clomethiazole interacts with the macromolecular GABAA-receptor complex in the central nervous system and in the anterior pituitary gland. Naundyn Schmidebergs Arch Pharmacol. 1989; 339:397�402.
- Cross AJ, Stirling JM, Robinson TN, BowenDM, Francis PT, Green AR. The modulation by clomethiazole of the GABAA-receptor complex in rat brain. Br J Pharmacol. 1989;98:284–290.
- Lyden PD. GABA and neuroprotection. In: Cross AJ, Green AR, eds. Neuroprotective Agents and Cerebral Ischemia. London: AP Ltd; 1997;233–258.
- Hock NH. Neuroprotective and thrombolytic agents: advances in stroke treatment. J Neurosci Nurs. 1998;30:6.